These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 12484569

  • 1. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.
    Kaneko K, Yoshida K, Arima K, Ohara S, Miyajima H, Kato T, Ohta M, Ikeda SI.
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1069-77. PubMed ID: 12484569
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aceruloplasminemia.
    Miyajima H.
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [Abstract] [Full Text] [Related]

  • 4. Molecular and pathological basis of aceruloplasminemia.
    Kono S, Miyajima H.
    Biol Res; 2006 Feb; 39(1):15-23. PubMed ID: 16629161
    [Abstract] [Full Text] [Related]

  • 5. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia.
    Oide T, Yoshida K, Kaneko K, Ohta M, Arima K.
    Neuropathol Appl Neurobiol; 2006 Apr; 32(2):170-6. PubMed ID: 16599945
    [Abstract] [Full Text] [Related]

  • 6. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain.
    Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, Ikeda S.
    Free Radic Res; 2002 Mar; 36(3):303-6. PubMed ID: 12071349
    [Abstract] [Full Text] [Related]

  • 7. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [Abstract] [Full Text] [Related]

  • 8. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness.
    Kaneko K, Hineno A, Yoshida K, Ohara S, Morita H, Ikeda S.
    Hum Pathol; 2012 Mar; 43(3):451-6. PubMed ID: 21889188
    [Abstract] [Full Text] [Related]

  • 9. Increased lipid peroxidation in the brains of aceruloplasminemia patients.
    Yoshida K, Kaneko K, Miyajima H, Tokuda T, Nakamura A, Kato M, Ikeda S.
    J Neurol Sci; 2000 Apr 15; 175(2):91-5. PubMed ID: 10831768
    [Abstract] [Full Text] [Related]

  • 10. Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia.
    Oshiro S, Kawamura K, Zhang C, Sone T, Morioka MS, Kobayashi S, Nakajima K.
    Biochim Biophys Acta; 2008 Feb 15; 1782(2):109-17. PubMed ID: 18187051
    [Abstract] [Full Text] [Related]

  • 11. Aceruloplasminemia.
    Kono S.
    Curr Drug Targets; 2012 Aug 15; 13(9):1190-9. PubMed ID: 22515740
    [Abstract] [Full Text] [Related]

  • 12. Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice.
    Kaneko K, Hineno A, Yoshida K, Ikeda S.
    Neurosci Lett; 2008 Nov 28; 446(1):56-8. PubMed ID: 18804145
    [Abstract] [Full Text] [Related]

  • 13. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF, Perry G, Miyajima H, Atwood CS, Riveros-Angel M, Lyons PF, Siedlak SL, Smith MA, Castellani RJ.
    Neuropathology; 2008 Oct 28; 28(5):466-71. PubMed ID: 18282164
    [Abstract] [Full Text] [Related]

  • 14. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A, Conti A, Cremonesi M, D'Adamo P, Gilberti E, Apostoli P, Cannistraci CV, Piperno A, David S, Alessio M.
    EMBO Mol Med; 2018 Jan 28; 10(1):91-106. PubMed ID: 29183916
    [Abstract] [Full Text] [Related]

  • 15. [Pathological study on central nervous system of patients with hereditary ceruloplasmin deficiency].
    Kawanami T.
    Nihon Naika Gakkai Zasshi; 2004 Aug 10; 93(8):1585-90. PubMed ID: 15384687
    [No Abstract] [Full Text] [Related]

  • 16. Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains.
    Miyajima H, Kono S, Takahashi Y, Sugimoto M.
    Blood Cells Mol Dis; 2002 Aug 10; 29(3):433-8. PubMed ID: 12547232
    [Abstract] [Full Text] [Related]

  • 17. Aceruloplasminemia: an update.
    Kono S.
    Int Rev Neurobiol; 2013 Aug 10; 110():125-51. PubMed ID: 24209437
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
    Yoshida K, Hayashi H, Wakusawa S, Shigemasa R, Koide R, Ishikawa T, Tatsumi Y, Kato K, Ohara S, Ikeda SI.
    Biol Trace Elem Res; 2017 Jan 10; 175(1):79-86. PubMed ID: 27272717
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.